PBX-003

N/A

Report date: 2024/08/23 11:05:07

Base Information

Drug NamePBX-003
Drug Alias NamePBX-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPinotbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesProEn Therapeutics IncPinotbio Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsHead and Neck NeoplasmsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A